查看购物车
  • Traditional Chinese
  • English
  • Japanese
  • Korean
封面
市场调查报告书
商品编码
1541256

2024-2032 年按药物类别、产品类型、治疗类型、给药途径和地区分類的气喘治疗市场报告

Asthma Therapeutics Market Report by Drug Class, Product Type, Treatment Type, Route of Administration, and Region 2024-2032
出版日期: | 出版商: IMARC | 英文 141 Pages | 商品交期: 2-3个工作天内

价格

IMARC Group年，全球气喘治疗市场规模达到 180 亿美元。

气喘治疗药物是指用于治疗气喘的各种药物。气喘通常由室内和室外致病因素引发，包括污染、过敏原和灰尘。这些治疗药物通常是支气管扩张剂和抗发炎药，包括皮质类固醇、长效β受体激动剂（LABA）、甲基黄嘌呤、免疫调节剂和白三烯调节剂。也使用许多可以吸入、注射或口服给药的合併治疗药物。这些药物可扩张进入肺部的通道，使空气流动以改善呼吸。它们还有助于清除肺部的黏液，从而轻鬆咳出。

气喘治疗市场趋势：

气喘和其他呼吸系统疾病的盛行率不断上升，以及诊断技术的改进，是推动市场成长的关键因素之一。此外，大众对有效气喘治疗方法的认识不断提高也推动了市场的成长。例如，气喘患者主要使用吸入性皮质类固醇进行治疗，晚期或持续性气喘患者则使用针对特定目标的药物进行治疗。对阻断免疫球蛋白 E 和特定细胞因子的单株抗体 (mAb) 也有广泛的需求。用于治疗呼吸系统疾病的联合疗法的发展是另一个生长诱导因素。医疗保健支出的增加、医学领域广泛的研究和开发（R＆D）活动以及医疗保健基础设施的改善是预计进一步推动市场的其他因素。

本报告回答的关键问题

  • 2023 年全球气喘治疗市场规模有多大？ 2024-2032年全球气喘治疗市场的预期成长率是多少？
  • 推动全球气喘治疗市场的关键因素是什么？
  • COVID-19 对全球气喘治疗市场有何影响？
  • 根据药物类别，全球气喘治疗市场的细分如何？
  • 根据产品类型，全球气喘治疗市场的细分如何？
  • 根据治疗类型，全球气喘治疗市场的细分如何？
  • 根据给药途径，全球气喘治疗市场的细分如何？
  • 全球气喘治疗市场的关键地区有哪些？
  • 谁是全球气喘治疗市场的主要参与者/公司？

目录

第一章：前言

第 2 章：范围与方法

  • 研究目的
  • 利害关係人
  • 数据来源
    • 主要来源
    • 二手资料
  • 市场预测
    • 自下而上的方法
    • 自上而下的方法
  • 预测方法

第 3 章：执行摘要

第 4 章：简介

  • 概述
  • 主要行业趋势

第 5 章：全球气喘治疗市场

  • 市场概况
  • 市场表现
  • COVID-19 的影响
  • 市场预测

第 6 章：市场区隔：依药物类别

  • 抗发炎药
    • 市场趋势
    • 市场预测
  • 支气管扩张剂
    • 市场趋势
    • 市场预测
  • 联合疗法
    • 市场趋势
    • 市场预测

第 7 章：市场区隔：依产品类型

  • 吸入器
    • 市场趋势
    • 主要类型
      • 干粉吸入器
      • 定量吸入器
      • 软雾吸入器
    • 市场预测
  • 雾化器
    • 市场趋势
    • 主要类型
      • 气动雾化器
      • 超音波雾化器
      • 网状雾化器
    • 市场预测

第 8 章：市场区隔：依治疗类型

  • 快速缓解药物
    • 市场趋势
    • 市场预测
  • 长期气喘控制药物
    • 市场趋势
    • 市场预测

第 9 章：市场区隔：依管理途径

  • 吸入
    • 市场趋势
    • 市场预测
  • 口服
    • 市场趋势
    • 市场预测
  • 注射用
    • 市场趋势
    • 市场预测

第 10 章：市场区隔：按地区

  • 北美洲
    • 美国
    • 加拿大
  • 亚太地区
    • 中国
    • 日本
    • 印度
    • 韩国
    • 澳洲
    • 印尼
    • 其他的
  • 欧洲
    • 德国
    • 法国
    • 英国
    • 义大利
    • 西班牙
    • 俄罗斯
    • 其他的
  • 拉丁美洲
    • 巴西
    • 墨西哥
    • 其他的
  • 中东和非洲
    • 市场趋势
    • 市场细分：按国家/地区
    • 市场预测

第 11 章：SWOT 分析

  • 概述
  • 优势
  • 弱点
  • 机会
  • 威胁

第 12 章：价值链分析

第 13 章：波特五力分析

  • 概述
  • 买家的议价能力
  • 供应商的议价能力
  • 竞争程度
  • 新进入者的威胁
  • 替代品的威胁

第 14 章：价格分析

第15章：竞争格局

  • 市场结构
  • 关键参与者
  • 关键参与者简介
    • AstraZeneca PLC
    • Abbott Laboratories
    • Amgen Inc.
    • Biogen Inc.
    • Boehringer Ingelheim International GmbH
    • F. Hoffmann-La Roche Ltd.
    • GlaxoSmithKline Plc
    • Merck Sharp & Dohme Corp.
    • Novartis International AG
    • Sunovion Pharmaceuticals Inc.
    • Teva Pharmaceutical Industries Ltd.
Product Code: SR112024A2338

The global asthma therapeutics market size reached US$ 18 Billion in 2023. Looking forward, IMARC Group expects the market to reach US$ 22.0 Billion by 2032, exhibiting a growth rate (CAGR) of 1.9% during 2024-2032.

Asthma therapeutics refer to various pharmaceutical drugs that are used for the treatment of asthma. Asthma is usually triggered by indoor and outdoor causative agents, including pollution, allergens and dust. These therapeutics are usually bronchodilators and anti-inflammatory drugs, which include corticosteroids, long-acting beta-agonists (LABA), methylxanthine, immunomodulators and leukotriene modifiers. A number of combination therapy drugs are also used that can be inhaled, injected, or orally administered. These drugs expand the passageway into the lungs and enable the movement of air to improve breathing. They also aid in clearing mucus from the lungs that gets coughed out with ease.

Asthma Therapeutics Market Trends:

The increasing prevalence of asthma and other respiratory disorders, along with improvements in the diagnostic technologies, is one of the key factors driving the growth of the market. Furthermore, rising awareness among the masses regarding the availability of effective asthma therapeutics is also providing driving the market growth. For instance, asthmatic patients are primarily treated with inhaled corticosteroids and patients with advanced conditions or persistent asthma are treated with target-specific drugs. There is also an extensive demand for monoclonal antibodies (mAbs) that block immunoglobulin E and specific cytokines. The development of combination therapies for the treatment of respiratory diseases is acting as another growth-inducing factor. Increasing healthcare expenditures, extensive research, and development (R&D) activities in the field of medical sciences and improvements in the healthcare infrastructure are some of the other factors that are expected to drive the market further.

Key Market Segmentation:

IMARC Group provides an analysis of the key trends in each segment of the global asthma therapeutics market report, along with forecasts at the global, regional and country levels from 2024-2032. Our report has categorized the market based on drug class, product type, treatment type and route of administration.

Breakup by Drug Class:

Anti-Inflammatory Drugs

Bronchodilators

Combination Therapies

Breakup by Product Type:

Inhalers

Dry Powder Inhalers

Metered Dose Inhalers

Soft Mist Inhalers

Nebulizers

Pneumatic Nebulizers

Ultrasonic Nebulizers

Mesh Nebulizers

Breakup by Treatment Type:

Quick-Relief Medications

Long-Term Asthma Control Medications

Breakup by Route of Administration:

Inhalation

Oral

Parenteral

Breakup by Region:

North America

United States

Canada

Asia Pacific

China

Japan

India

South Korea

Australia

Indonesia

Others

Europe

Germany

France

United Kingdom

Italy

Spain

Russia

Others

Latin America

Brazil

Mexico

Others

Middle East and Africa

Competitive Landscape:

The report has also analysed the competitive landscape of the market with some of the key players being AstraZeneca PLC, Abbott Laboratories, Amgen Inc., Biogen Inc., Boehringer Ingelheim International GmbH, F. Hoffmann-La Roche Ltd., GlaxoSmithKline Plc, Merck Sharp & Dohme Corp., Novartis International AG, Sunovion Pharmaceuticals Inc. and Teva Pharmaceutical Industries Ltd.

Key Questions Answered in This Report

  • 1. What was the size of the global asthma therapeutics market in 2023?
  • 2. What is the expected growth rate of the global asthma therapeutics market during 2024-2032?
  • 3. What are the key factors driving the global asthma therapeutics market?
  • 4. What has been the impact of COVID-19 on the global asthma therapeutics market?
  • 5. What is the breakup of the global asthma therapeutics market based on the drug class?
  • 6. What is the breakup of the global asthma therapeutics market based on the product type?
  • 7. What is the breakup of the global asthma therapeutics market based on the treatment type?
  • 8. What is the breakup of the global asthma therapeutics market based on the route of administration?
  • 9. What are the key regions in the global asthma therapeutics market?
  • 10. Who are the key players/companies in the global asthma therapeutics market?

Table of Contents

1 Preface

2 Scope and Methodology

  • 2.1 Objectives of the Study
  • 2.2 Stakeholders
  • 2.3 Data Sources
    • 2.3.1 Primary Sources
    • 2.3.2 Secondary Sources
  • 2.4 Market Estimation
    • 2.4.1 Bottom-Up Approach
    • 2.4.2 Top-Down Approach
  • 2.5 Forecasting Methodology

3 Executive Summary

4 Introduction

  • 4.1 Overview
  • 4.2 Key Industry Trends

5 Global Asthma Therapeutics Market

  • 5.1 Market Overview
  • 5.2 Market Performance
  • 5.3 Impact of COVID-19
  • 5.4 Market Forecast

6 Market Breakup by Drug Class

  • 6.1 Anti-Inflammatory Drugs
    • 6.1.1 Market Trends
    • 6.1.2 Market Forecast
  • 6.2 Bronchodilators
    • 6.2.1 Market Trends
    • 6.2.2 Market Forecast
  • 6.3 Combination Therapies
    • 6.3.1 Market Trends
    • 6.3.2 Market Forecast

7 Market Breakup by Product Type

  • 7.1 Inhalers
    • 7.1.1 Market Trends
    • 7.1.2 Major Types
      • 7.1.2.1 Dry Powder Inhalers
      • 7.1.2.2 Metered Dose Inhalers
      • 7.1.2.3 Soft Mist Inhalers
    • 7.1.3 Market Forecast
  • 7.2 Nebulizers
    • 7.2.1 Market Trends
    • 7.2.2 Major Types
      • 7.2.2.1 Pneumatic Nebulizers
      • 7.2.2.2 Ultrasonic Nebulizers
      • 7.2.2.3 Mesh Nebulizers
    • 7.2.3 Market Forecast

8 Market Breakup by Treatment Type

  • 8.1 Quick-Relief Medications
    • 8.1.1 Market Trends
    • 8.1.2 Market Forecast
  • 8.2 Long-Term Asthma Control Medications
    • 8.2.1 Market Trends
    • 8.2.2 Market Forecast

9 Market Breakup by Route of Administration

  • 9.1 Inhalation
    • 9.1.1 Market Trends
    • 9.1.2 Market Forecast
  • 9.2 Oral
    • 9.2.1 Market Trends
    • 9.2.2 Market Forecast
  • 9.3 Parenteral
    • 9.3.1 Market Trends
    • 9.3.2 Market Forecast

10 Market Breakup by Region

  • 10.1 North America
    • 10.1.1 United States
      • 10.1.1.1 Market Trends
      • 10.1.1.2 Market Forecast
    • 10.1.2 Canada
      • 10.1.2.1 Market Trends
      • 10.1.2.2 Market Forecast
  • 10.2 Asia Pacific
    • 10.2.1 China
      • 10.2.1.1 Market Trends
      • 10.2.1.2 Market Forecast
    • 10.2.2 Japan
      • 10.2.2.1 Market Trends
      • 10.2.2.2 Market Forecast
    • 10.2.3 India
      • 10.2.3.1 Market Trends
      • 10.2.3.2 Market Forecast
    • 10.2.4 South Korea
      • 10.2.4.1 Market Trends
      • 10.2.4.2 Market Forecast
    • 10.2.5 Australia
      • 10.2.5.1 Market Trends
      • 10.2.5.2 Market Forecast
    • 10.2.6 Indonesia
      • 10.2.6.1 Market Trends
      • 10.2.6.2 Market Forecast
    • 10.2.7 Others
      • 10.2.7.1 Market Trends
      • 10.2.7.2 Market Forecast
  • 10.3 Europe
    • 10.3.1 Germany
      • 10.3.1.1 Market Trends
      • 10.3.1.2 Market Forecast
    • 10.3.2 France
      • 10.3.2.1 Market Trends
      • 10.3.2.2 Market Forecast
    • 10.3.3 United Kingdom
      • 10.3.3.1 Market Trends
      • 10.3.3.2 Market Forecast
    • 10.3.4 Italy
      • 10.3.4.1 Market Trends
      • 10.3.4.2 Market Forecast
    • 10.3.5 Spain
      • 10.3.5.1 Market Trends
      • 10.3.5.2 Market Forecast
    • 10.3.6 Russia
      • 10.3.6.1 Market Trends
      • 10.3.6.2 Market Forecast
    • 10.3.7 Others
      • 10.3.7.1 Market Trends
      • 10.3.7.2 Market Forecast
  • 10.4 Latin America
    • 10.4.1 Brazil
      • 10.4.1.1 Market Trends
      • 10.4.1.2 Market Forecast
    • 10.4.2 Mexico
      • 10.4.2.1 Market Trends
      • 10.4.2.2 Market Forecast
    • 10.4.3 Others
      • 10.4.3.1 Market Trends
      • 10.4.3.2 Market Forecast
  • 10.5 Middle East and Africa
    • 10.5.1 Market Trends
    • 10.5.2 Market Breakup by Country
    • 10.5.3 Market Forecast

11 SWOT Analysis

  • 11.1 Overview
  • 11.2 Strengths
  • 11.3 Weaknesses
  • 11.4 Opportunities
  • 11.5 Threats

12 Value Chain Analysis

13 Porters Five Forces Analysis

  • 13.1 Overview
  • 13.2 Bargaining Power of Buyers
  • 13.3 Bargaining Power of Suppliers
  • 13.4 Degree of Competition
  • 13.5 Threat of New Entrants
  • 13.6 Threat of Substitutes

14 Price Analysis

15 Competitive Landscape

  • 15.1 Market Structure
  • 15.2 Key Players
  • 15.3 Profiles of Key Players
    • 15.3.1 AstraZeneca PLC
      • 15.3.1.1 Company Overview
      • 15.3.1.2 Product Portfolio
      • 15.3.1.3 Financials
      • 15.3.1.4 SWOT Analysis
    • 15.3.2 Abbott Laboratories
      • 15.3.2.1 Company Overview
      • 15.3.2.2 Product Portfolio
      • 15.3.2.3 Financials
      • 15.3.2.4 SWOT Analysis
    • 15.3.3 Amgen Inc.
      • 15.3.3.1 Company Overview
      • 15.3.3.2 Product Portfolio
      • 15.3.3.3 Financials
      • 15.3.3.4 SWOT Analysis
    • 15.3.4 Biogen Inc.
      • 15.3.4.1 Company Overview
      • 15.3.4.2 Product Portfolio
      • 15.3.4.3 Financials
      • 15.3.4.4 SWOT Analysis
    • 15.3.5 Boehringer Ingelheim International GmbH
      • 15.3.5.1 Company Overview
      • 15.3.5.2 Product Portfolio
    • 15.3.6 F. Hoffmann-La Roche Ltd.
      • 15.3.6.1 Company Overview
      • 15.3.6.2 Product Portfolio
      • 15.3.6.3 SWOT Analysis
    • 15.3.7 GlaxoSmithKline Plc
      • 15.3.7.1 Company Overview
      • 15.3.7.2 Product Portfolio
      • 15.3.7.3 Financials
      • 15.3.7.4 SWOT Analysis
    • 15.3.8 Merck Sharp & Dohme Corp.
      • 15.3.8.1 Company Overview
      • 15.3.8.2 Product Portfolio
      • 15.3.8.3 Financials
      • 15.3.8.4 SWOT Analysis
    • 15.3.9 Novartis International AG
      • 15.3.9.1 Company Overview
      • 15.3.9.2 Product Portfolio
      • 15.3.9.3 Financials
      • 15.3.9.4 SWOT Analysis
    • 15.3.10 Sunovion Pharmaceuticals Inc.
      • 15.3.10.1 Company Overview
      • 15.3.10.2 Product Portfolio
      • 15.3.10.3 SWOT Analysis
    • 15.3.11 Teva Pharmaceutical Industries Ltd.
      • 15.3.11.1 Company Overview
      • 15.3.11.2 Product Portfolio
      • 15.3.11.3 Financials
      • 15.3.11.4 SWOT Analysis

List of Figures

  • Figure 1: Global: Asthma Therapeutics Market: Major Drivers and Challenges
  • Figure 2: Global: Asthma Therapeutics Market: Sales Value (in Billion US$), 2018-2023
  • Figure 3: Global: Asthma Therapeutics Market: Breakup by Drug Class (in %), 2023
  • Figure 4: Global: Asthma Therapeutics Market: Breakup by Product Type (in %), 2023
  • Figure 5: Global: Asthma Therapeutics Market: Breakup by Treatment Type (in %), 2023
  • Figure 6: Global: Asthma Therapeutics Market: Breakup by Route of Administration (in %), 2023
  • Figure 7: Global: Asthma Therapeutics Market: Breakup by Region (in %), 2023
  • Figure 8: Global: Asthma Therapeutics Market Forecast: Sales Value (in Billion US$), 2024-2032
  • Figure 9: Global: Asthma Therapeutics (Anti-Inflammatory Drugs) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 10: Global: Asthma Therapeutics (Anti-Inflammatory Drugs) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 11: Global: Asthma Therapeutics (Bronchodilators) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 12: Global: Asthma Therapeutics (Bronchodilators) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 13: Global: Asthma Therapeutics (Combination Therapies) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 14: Global: Asthma Therapeutics (Combination Therapies) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 15: Global: Asthma Therapeutics (Inhalers) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 16: Global: Asthma Therapeutics (Inhalers) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 17: Global: Asthma Therapeutics (Nebulizers) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 18: Global: Asthma Therapeutics (Nebulizers) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 19: Global: Asthma Therapeutics (Quick-Relief Medications) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 20: Global: Asthma Therapeutics (Quick-Relief Medications) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 21: Global: Asthma Therapeutics (Long-Term Asthma Control Medications) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 22: Global: Asthma Therapeutics (Long-Term Asthma Control Medications) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 23: Global: Asthma Therapeutics (Inhalation) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 24: Global: Asthma Therapeutics (Inhalation) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 25: Global: Asthma Therapeutics (Oral) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 26: Global: Asthma Therapeutics (Oral) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 27: Global: Asthma Therapeutics (Parenteral) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 28: Global: Asthma Therapeutics (Parenteral) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 29: North America: Asthma Therapeutics Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 30: North America: Asthma Therapeutics Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 31: United States: Asthma Therapeutics Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 32: United States: Asthma Therapeutics Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 33: Canada: Asthma Therapeutics Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 34: Canada: Asthma Therapeutics Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 35: Asia Pacific: Asthma Therapeutics Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 36: Asia Pacific: Asthma Therapeutics Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 37: China: Asthma Therapeutics Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 38: China: Asthma Therapeutics Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 39: Japan: Asthma Therapeutics Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 40: Japan: Asthma Therapeutics Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 41: India: Asthma Therapeutics Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 42: India: Asthma Therapeutics Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 43: South Korea: Asthma Therapeutics Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 44: South Korea: Asthma Therapeutics Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 45: Australia: Asthma Therapeutics Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 46: Australia: Asthma Therapeutics Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 47: Indonesia: Asthma Therapeutics Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 48: Indonesia: Asthma Therapeutics Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 49: Others: Asthma Therapeutics Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 50: Others: Asthma Therapeutics Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 51: Europe: Asthma Therapeutics Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 52: Europe: Asthma Therapeutics Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 53: Germany: Asthma Therapeutics Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 54: Germany: Asthma Therapeutics Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 55: France: Asthma Therapeutics Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 56: France: Asthma Therapeutics Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 57: United Kingdom: Asthma Therapeutics Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 58: United Kingdom: Asthma Therapeutics Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 59: Italy: Asthma Therapeutics Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 60: Italy: Asthma Therapeutics Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 61: Spain: Asthma Therapeutics Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 62: Spain: Asthma Therapeutics Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 63: Russia: Asthma Therapeutics Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 64: Russia: Asthma Therapeutics Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 65: Others: Asthma Therapeutics Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 66: Others: Asthma Therapeutics Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 67: Latin America: Asthma Therapeutics Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 68: Latin America: Asthma Therapeutics Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 69: Brazil: Asthma Therapeutics Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 70: Brazil: Asthma Therapeutics Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 71: Mexico: Asthma Therapeutics Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 72: Mexico: Asthma Therapeutics Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 73: Others: Asthma Therapeutics Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 74: Others: Asthma Therapeutics Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 75: Middle East and Africa: Asthma Therapeutics Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 76: Middle East and Africa: Asthma Therapeutics Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 77: Global: Asthma Therapeutics Industry: SWOT Analysis
  • Figure 78: Global: Asthma Therapeutics Industry: Value Chain Analysis
  • Figure 79: Global: Asthma Therapeutics Industry: Porter's Five Forces Analysis

List of Tables

  • Table 1: Global: Asthma Therapeutics Market: Key Industry Highlights, 2023 and 2032
  • Table 2: Global: Asthma Therapeutics Market Forecast: Breakup by Drug Class (in Million US$), 2024-2032
  • Table 3: Global: Asthma Therapeutics Market Forecast: Breakup by Product Type (in Million US$), 2024-2032
  • Table 4: Global: Asthma Therapeutics Market Forecast: Breakup by Treatment Type (in Million US$), 2024-2032
  • Table 5: Global: Asthma Therapeutics Market Forecast: Breakup by Route of Administration (in Million US$), 2024-2032
  • Table 6: Global: Asthma Therapeutics Market Forecast: Breakup by Region (in Million US$), 2024-2032
  • Table 7: Global: Asthma Therapeutics Market Structure
  • Table 8: Global: Asthma Therapeutics Market: Key Players